TEX13B

Across TCGA pan-cancer cohorts, TEX13B RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated TEX13B data layer compared with 5 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher TEX13B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TEX13B expression acts as an unfavorable survival marker, although some lineages such as READ and ESCA show a favorable association.

DLBC, KICH, and MESO are the cancer types where TEX13B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	II,III,IV	0.355	0.865	<.001	107	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
MESO	OS	Tertile	All	0.326	0.562	.014	63	view →
CHOL	DFS	Tertile	All	0.066	0.519	.013	45	view →
HNSC	OS	Tertile	IV	0.628	0.768	.005	40	view →
UCEC	DFS	Tertile	All	0.511	0.665	.002	36	view →
KIRC	DFS	Quartile	All	0.455	0.688	.003	30	view →
LIHC	OS	Tertile	II,III,IV	0.417	0.725	.002	27	view →
READ	OS	Tertile	All	1.000	0.883	.011	26	view →
ESCA	OS	Tertile	IV	0.738	0.264	.024	24	view →
LUAD	DFS	Tertile	IV	0.319	0.747	.007	18	view →
KIRP	OS	Tertile	IV	0.111	0.503	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

TEX13B–DLBC (OS)

Open the DLBC breakdown →